V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins

S Anang, S Zhang, C Fritschi, TJ Chiu, D Yang… - Journal of …, 2023 - Am Soc Microbiol
ABSTRACT CD4-mimetic compounds (CD4mcs) bind the human immunodeficiency virus
(HIV-1) gp120 exterior envelope glycoprotein (Env) and compete for binding to CD4, the …

The SIV envelope glycoprotein, viral tropism, and pathogenesis: novel insights from nonhuman primate models of AIDS

AE Swanstrom, GQ Del Prete, C Deleage… - Current HIV …, 2018 - ingentaconnect.com
Background: Cellular tropism of human immunodeficiency virus (HIV-1) is closely linked to
interactions between the viral envelope glycoprotein (Env) with CD4 and chemokine …

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys

KE Stephenson, H Li, BD Walker, NL Michael… - Retrovirology, 2012 - Springer
Background A vaccine for HIV-1 would ideally block HIV-1 acquisition as well as durably
control viral replication in breakthrough infections. A recently published study showed that …

[HTML][HTML] Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes

M Asmal, C Luedemann, CL Lavine, LV Mach… - Virology, 2015 - Elsevier
Simian-human immunodeficiency viruses (SHIVs) that mirror natural transmitted/founder
(T/F) viruses in man are needed for evaluation of HIV-1 vaccine candidates in nonhuman …

New SHIVs and improved design strategy for modeling HIV-1 transmission, immunopathogenesis, prevention, and cure

H Li, S Wang, FH Lee, RS Roark, AI Murphy… - Journal of …, 2021 - Am Soc Microbiol
Previously, we showed that substitution of HIV-1 envelope (Env) residue 375-Ser by bulky
aromatic residues enhances binding to rhesus CD4 and enables primary HIV-1 Envs to …

[HTML][HTML] Breaking barriers to an AIDS model with macaque-tropic HIV-1 derivatives

R Thippeshappa, H Ruan, JT Kimata - Biology, 2012 - mdpi.com
The development of an animal model of human immunodeficiency virus type 1 (HIV-1)/AIDS
that is suitable for preclinical testing of antiretroviral therapy, vaccines, curative strategies …

Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages

W Fischer, C Apetrei, ML Santiago, Y Li… - Journal of …, 2012 - Am Soc Microbiol
Simian immunodeficiency virus (SIV) infection of rhesus macaques causes immune
depletion and disease closely resembling human AIDS and is well recognized as the most …

Differential outcomes following optimization of simian-human immunodeficiency viruses from clades AE, B, and C

LJ Tartaglia, S Gupte, KC Pastores, S Trott… - Journal of …, 2020 - Am Soc Microbiol
Simian-human immunodeficiency virus (SHIV) infection of rhesus monkeys is an important
preclinical model for human immunodeficiency virus type 1 (HIV-1) vaccines, therapeutics …

[HTML][HTML] Infection pressure in apes has driven selection for CD4 alleles that resist lentivirus (HIV/SIV) infection

CJ Warren, A Barbachano-Guerrero, VL Bauer… - eLife, 2024 - elifesciences.org
Simian immunodeficiency viruses (SIVs) comprise a large group of primate lentiviruses that
endemically infect African monkeys. HIV-1 spilled over to humans from this viral reservoir …

[HTML][HTML] Macaque interferon-induced transmembrane proteins limit replication of SHIV strains in an Envelope-dependent manner

A Sharma, RN McLaughlin Jr, RS Basom… - PLoS …, 2019 - journals.plos.org
HIV-1 does not persistently infect macaques due in part to restriction by several macaque
host factors. This has been partially circumvented by generating chimeric SIV/HIV-1 viruses …